Evidence map›Paper›PMID 32665702›Full record

ArticleGenetics in medicine : official journal of the American College of Medical Genetics2020

Reduced penetrance of pathogenic ACMG variants in a deeply phenotyped cohort study and evaluation of ClinVar classification over time.

Jeroen van Rooij, Pascal Arp, Linda Broer, Joost Verlouw, Frank van Rooij, Robert Kraaij, André Uitterlinden, Annemieke J M H Verkerk

Open access · hybridAbstract read
In one paragraph

Article in Genetics in medicine : official journal of the American College of Medical Genetics, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed, 2 pooled it
5.0field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 2 syntheses or guidelines pooled it, 44 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Prevalence of Monogenic Bone Disorders in a Dutch Cohort of Atypical Femur Fracture Patients.Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research · 2023
    Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Frequency of truncating FLCN variants and Birt-Hogg-Dubé-associated phenotypes in a health care system population.Genetics in medicine : official journal of the American College of Medical Genetics · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Jeroen van RooijDepartment of Internal Medicine, Erasmus Medical Centre, Rotterdam, The Netherlands. j.vanrooij@erasmusmc.nl.ORCID http://orcid.org/0000-0001-9754-073X
Pascal ArpDepartment of Internal Medicine, Erasmus Medical Centre, Rotterdam, The Netherlands.
Linda BroerDepartment of Internal Medicine, Erasmus Medical Centre, Rotterdam, The Netherlands.
Joost VerlouwDepartment of Internal Medicine, Erasmus Medical Centre, Rotterdam, The Netherlands.
Frank van RooijDepartment of Epidemiology, Erasmus Medical Centre, Rotterdam, The Netherlands.
Robert KraaijDepartment of Internal Medicine, Erasmus Medical Centre, Rotterdam, The Netherlands.
André UitterlindenDepartment of Internal Medicine, Erasmus Medical Centre, Rotterdam, The Netherlands.
Annemieke J M H VerkerkDepartment of Internal Medicine, Erasmus Medical Centre, Rotterdam, The Netherlands.
Erasmus University Rotterdam · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeWe studied the penetrance of pathogenically classified variants in an elderly Dutch population from the Rotterdam Study, for which deep phenotyping is available. We screened the 59 actionable genes for which reporting of known pathogenic variants was recommended by the American College of Medical Genetics and Genomics (ACMG), and demonstrate that determining what constitutes a known pathogenic variant can be quite challenging.

methodsWe defined "known pathogenic" as classified pathogenic by both ClinVar and the Human Gene Mutation Database (HGMD). In 2628 individuals, we performed exome sequencing and identified known pathogenic variants. We investigated the clinical records of carriers and evaluated clinical events during 25 years of follow-up for evidence of variant pathogenicity.

resultsOf 3815 variants detected in the 59 ACMG genes, 17 variants were considered known pathogenic. For 14/17 variants the ClinVar classification had changed over time. Of 24 confirmed carriers of these variants, we observed at least one clinical event possibly caused by the variant in only three participants (13%).

conclusionWe show that the definition of "known pathogenic" is often unclear and should be approached carefully. Additionally variants marked as known pathogenic do not always have clinical impact on their carriers. Definition and classification of true (individual) expected pathogenic impact should be defined carefully.

Indexed as

Genetic VariationGenomicsAgedCohort StudiesHumansPenetrancePhenotypeACMG genesclinical interpretationexome sequencingpathogenic variantspenetrance

Identifiers

PMID32665702
PMCPMC7605437
OpenAlexW3042286209

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.